About Venomtech
Venomtech is a company based in Sandwich (United Kingdom) founded in 2010. Venomtech has raised $1.36 million across 4 funding rounds. The company has 6 employees as of February 28, 2023. Venomtech operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Sandwich, United Kingdom
- Employees 6 as on 28 Feb, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Venomtech Limited
- Date of Incorporation 16 Mar, 2010
- Jurisdiction SANDWICH, KENT, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.36 M (USD)
in 4 rounds
-
Latest Funding Round
$395.25 K (USD), Seed
Sep 10, 2021
-
Investors
Not available
-
Employee Count
6
as on Feb 28, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Venomtech
Venomtech has successfully raised a total of $1.36M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $395.25 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Venomtech
Investment portfolio details for Venomtech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Venomtech
Detailed financials for Venomtech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Venomtech Comparisons
Peer comparison for Venomtech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Venomtech
Venomtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Venomtech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Venomtech
Complete news archive for Venomtech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venomtech
Venomtech was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Venomtech is headquartered in Sandwich, United Kingdom.
Venomtech is a funded company, having raised a total of $1.36M across 4 funding rounds to date.
As of Feb 28, 2023, the latest employee count at Venomtech is 6.
Venomtech was founded in 2010 in Sandwich, United Kingdom, within the bioprospecting and biological research sector. Compound libraries of animal venoms are supplied for hit-to-tool screening and biotherapeutic development. Molecular biology and biological safety consultancy, along with education, are offered. Targeted Venom Discovery Arrays (TVDAs), custom libraries of peptide proteins, and venom components are provided, including hit-to-lead services for drug discovery.
Venomtech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.